InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Bristol Myers Squibb

BMY Clue Score46
United States Fiscal year ends December CIK 0000014272
$59.12 -0.77% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $59.12 +2.96% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueNet income
Fiscal year 2016Revenue19.43Net income4.46EPS, diluted2.65Fiscal year 2017Revenue20.78 +6.9%Net income1.01 −77.4%EPS, diluted0.61 −77.0%Fiscal year 2018Revenue22.56 +8.6%Net income4.92 +388.6%EPS, diluted3.01 +393.4%Fiscal year 2019Revenue26.15 +15.9%Net income3.44 −30.1%EPS, diluted2.01 −33.2%Fiscal year 2020Revenue42.52 +62.6%Net income−9.02 −362.1%EPS, diluted−3.99 −298.5%Fiscal year 2021Revenue46.39 +9.1%Net income6.99EPS, diluted3.12Fiscal year 2022Revenue46.16 −0.5%Net income6.33 −9.5%EPS, diluted2.95 −5.4%Fiscal year 2023Revenue45.01 −2.5%Net income8.03 +26.8%EPS, diluted3.86 +30.8%Fiscal year 2024Revenue48.30 +7.3%Net income−8.95 −211.5%EPS, diluted−4.41 −214.2%Fiscal year 2025Revenue48.19 −0.2%Net income7.05EPS, diluted3.46
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 19.43 20.78 22.56 26.15 42.52 46.39 46.16 45.01 48.30 48.19
Growth +6.9% +8.6% +15.9% +62.6% +9.1% −0.5% −2.5% +7.3% −0.2%
Net income 4.46 1.01 4.92 3.44 −9.02 6.99 6.33 8.03 −8.95 7.05
Growth −77.4% +388.6% −30.1% −362.1% −9.5% +26.8% −211.5%
EPS, diluted 2.65 0.61 3.01 2.01 −3.99 3.12 2.95 3.86 −4.41 3.46
Growth −77.0% +393.4% −33.2% −298.5% −5.4% +30.8% −214.2%

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginNet margin
Fiscal year 2016Gross margin74.5%Net margin22.9%Free cash flow margin9.5%Fiscal year 2017Gross margin70.7%Net margin4.8%Free cash flow margin20.3%Fiscal year 2018Gross margin71.3%Net margin21.8%Free cash flow margin27.1%Fiscal year 2019Gross margin69.1%Net margin13.2%Free cash flow margin28.2%Fiscal year 2020Gross margin72.3%Net margin−21.2%Free cash flow margin31.3%Fiscal year 2021Net margin15.1%Free cash flow margin32.8%Fiscal year 2022Net margin13.7%Free cash flow margin25.9%Fiscal year 2023Net margin17.8%Free cash flow margin28.1%Fiscal year 2024Net margin−18.5%Free cash flow margin28.9%Fiscal year 2025Net margin14.6%Free cash flow margin26.7%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Gross margin 74.5% 70.7% 71.3% 69.1% 72.3% n/a n/a n/a n/a n/a
Net margin 22.9% 4.8% 21.8% 13.2% −21.2% 15.1% 13.7% 17.8% −18.5% 14.6%
Free cash flow margin 9.5% 20.3% 27.1% 28.2% 31.3% 32.8% 25.9% 28.1% 28.9% 26.7%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow3.06Capital expenditure−1.22Free cash flow1.84Buybacks−0.23Dividends paid−2.55Fiscal year 2017Operating cash flow5.28Capital expenditure−1.06Free cash flow4.22 +129.0%Buybacks−2.47Dividends paid−2.58Fiscal year 2018Operating cash flow7.07Capital expenditure−0.95Free cash flow6.12 +44.9%Buybacks−0.32Dividends paid−2.61Fiscal year 2019Operating cash flow8.21Capital expenditure−0.84Free cash flow7.37 +20.6%Buybacks−7.30Dividends paid−2.68Fiscal year 2020Operating cash flow14.05Capital expenditure−0.75Free cash flow13.30 +80.3%Buybacks−1.55Dividends paid−4.08Fiscal year 2021Operating cash flow16.21Capital expenditure−0.97Free cash flow15.23 +14.5%Buybacks−6.29Dividends paid−4.40Fiscal year 2022Operating cash flow13.07Capital expenditure−1.12Free cash flow11.95 −21.6%Buybacks−8.00Dividends paid−4.63Fiscal year 2023Operating cash flow13.86Capital expenditure−1.21Free cash flow12.65 +5.9%Buybacks−5.16Dividends paid−4.74Fiscal year 2024Operating cash flow15.19Capital expenditure−1.25Free cash flow13.94 +10.2%Buybacks0.00Dividends paid−4.86Fiscal year 2025Operating cash flow14.16Capital expenditure−1.31Free cash flow12.85 −7.9%Buybacks0.00Dividends paid−5.05
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow 3.06 5.28 7.07 8.21 14.05 16.21 13.07 13.86 15.19 14.16
Capital expenditure −1.22 −1.06 −0.95 −0.84 −0.75 −0.97 −1.12 −1.21 −1.25 −1.31
Free cash flow 1.84 4.22 6.12 7.37 13.30 15.23 11.95 12.65 13.94 12.85
Growth +129.0% +44.9% +20.6% +80.3% +14.5% −21.6% +5.9% +10.2% −7.9%
Buybacks −0.23 −2.47 −0.32 −7.30 −1.55 −6.29 −8.00 −5.16 0.00 0.00
Dividends paid −2.55 −2.58 −2.61 −2.68 −4.08 −4.40 −4.63 −4.74 −4.86 −5.05

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2016Cash4.24Total debt6.47Net cash (debt)−2.23Shareholders’ equity16.18Debt to equity0.40Fiscal year 2017Cash5.42Total debt6.98Net cash (debt)−1.55Shareholders’ equity11.74Debt to equity0.59Fiscal year 2018Cash6.91Total debt6.90Net cash (debt)0.02Shareholders’ equity14.03Debt to equity0.49Fiscal year 2019Cash12.35Total debt46.15Net cash (debt)−33.80Shareholders’ equity51.60Debt to equity0.89Fiscal year 2020Cash14.55Total debt50.34Net cash (debt)−35.79Shareholders’ equity37.82Debt to equity1.33Fiscal year 2021Cash13.98Total debt44.37Net cash (debt)−30.39Shareholders’ equity35.95Debt to equity1.23Fiscal year 2022Cash9.12Total debt38.95Net cash (debt)−29.83Shareholders’ equity31.06Debt to equity1.25Fiscal year 2023Cash11.46Total debt39.53Net cash (debt)−28.06Shareholders’ equity29.43Debt to equity1.34Fiscal year 2024Cash10.35Total debt49.43Net cash (debt)−39.09Shareholders’ equity16.34Debt to equity3.03Fiscal year 2025Cash10.21Total debt44.83Net cash (debt)−34.62Shareholders’ equity18.47Debt to equity2.43
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 4.24 5.42 6.91 12.35 14.55 13.98 9.12 11.46 10.35 10.21
Total debt 6.47 6.98 6.90 46.15 50.34 44.37 38.95 39.53 49.43 44.83
Net cash (debt) −2.23 −1.55 0.02 −33.80 −35.79 −30.39 −29.83 −28.06 −39.09 −34.62
Shareholders’ equity 16.18 11.74 14.03 51.60 37.82 35.95 31.06 29.43 16.34 18.47
Debt to equity 0.40 0.59 0.49 0.89 1.33 1.23 1.25 1.34 3.03 2.43

In billions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Cash flow

In billions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Operations
3.06 5.28 7.07 8.21 14.05 16.21 13.07 13.86 15.19 14.16
Growth +72.5% +34.0% +16.2% +71.2% +15.3% −19.4% +6.1% +9.6% −6.8%
0.38 0.79 0.64 1.75 10.38 10.69 10.28 9.76 9.60 4.01
Investment
−1.22 −1.06 −0.95 −0.84 −0.75 −0.97 −1.12 −1.21 −1.25 −1.31
calc 1.84 4.22 6.12 7.37 13.30 15.23 11.95 12.65 13.94 12.85
Growth +129.0% +44.9% +20.6% +80.3% +14.5% −21.6% +5.9% +10.2% −7.9%
calc 1.10 2.55 3.74 4.31 5.89 6.79 5.57 6.09 6.88 6.30
1.48 −0.07 −2.00 −9.91 −10.86 −0.54 −1.06 −2.30 −21.35 −4.13
Financing
−2.65 −4.08 −3.54 7.62 −1.15 −16.22 −16.96 −9.42 5.13 −10.35
−2.55 −2.58 −2.61 −2.68 −4.08 −4.40 −4.63 −4.74 −4.86 −5.05
−0.23 −2.47 −0.32 −7.30 −1.55 −6.29 −8.00 −5.16 0.00 0.00

Lines marked calc are worked out here from filed figures; point at one for how. Capital expenditure, dividends and buybacks are shown as money out, so negative.